MDT Medtronic Plc

Medtronic Foundation Commits an Additional $10M to Global COVID-19 Efforts

Medtronic Foundation Commits an Additional $10M to Global COVID-19 Efforts

Donation is Focused on Supporting and Equipping Frontline Health Workers Globally and Investing in Responsive Local Efforts that Assist Vulnerable Populations

DUBLIN and MINNEAPOLIS, March 25, 2020 (GLOBE NEWSWIRE) --  The Medtronic Foundation announced an additional $10M in contributions to COVID-19 relief efforts across the globe. This adds to the initial charitable contributions made by Medtronic and the Medtronic Foundation of $1.2M in February to support immediate response efforts.

The Medtronic Foundation’s global and local response includes a comprehensive approach that is inclusive of cash contributions to over a dozen health and community nonprofits and will be used to fund:

  •  Training and supervising frontline health workers
  •  Ensuring the safety and well-being of frontline health workers, including provision of personal protective equipment (PPE) and critical supplies
  •  Supporting preparedness efforts for the health workforce, including surge capacity; caring for chronic, at-risk patients; and remote patient monitoring
  •  Offering local community support of health, economic and food assistance for vulnerable populations
  •  Providing flexible support to nonprofit partners working in underserved communities

“With roots in the world’s largest medical technology company, the Medtronic Foundation has a responsibility to be a leader on global issues impacting access to healthcare,” said Paurvi Bhatt, president of the Medtronic Foundation. “During this unprecedented global health crisis, we are committed to supporting and equipping the courageous frontline health workers who are delivering critical care to those in need. Through volunteerism and financial investments, we continue to partner with thought leading partners working globally, nationally and locally – with the flexibility and investment required to meet this critical need.”

In addition to financial contributions, the Medtronic Foundation is organizing virtual volunteer opportunities to help the more than 90,000 Medtronic employees globally support non-profit organizations that are responding to this global health crisis. Many of these opportunities will engage Medtronic employees in skills-based volunteerism where they leverage their professional skills to support organizations in need.

The Medtronic Foundation also will continue to match Medtronic employee donations to nonprofit organizations. These efforts will contribute to the immediate response, and as the situation evolves, the Medtronic Foundation will evaluate needs and consider additional contributions and volunteer opportunities as appropriate.



About Medtronic Foundation

Medtronic plc is the sole funder of Medtronic Foundation, whose focus is on improving health for underserved populations worldwide, as well as supporting communities in which Medtronic employees live and give. For more information, please visit .

-end-



Allison Frailich

Public Relations

Erika Winkels

Public Relations

EN
25/03/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Medtronic Plc

Research Team ACF
  • Research Team ACF

KDST + NLSP Combined Core Investment Case 29052025

We consider the merged platform Kadimastem (KDST.TA) + NLS Pharmaceutics (NLSP:NasdaqCM). We provide an investment case analysis and a selection of merged metrics prior to any synergies. The merger creates a cross-platform pre-revenue biotech with lead programs including a proprietary stem-differentiation platform capable of delivering scalable therapies for replacing lost or damaged cells; IsletRx could revolutionize insulin production for Type 1 diabetes (T1D) patients; AstroRx® targets neurod...

Research Team ACF
  • Research Team ACF

ACF Thematic Research Regenerative Medicine Diabetes Treatment & Innov...

Diabetes mellitus, Type 1 (T1D) and Type 2 (T2D, 85-90% of cases), is a USD ~75bn global therapy market. Global economic costs of diabetes may exceed USD1 trn today and USD 450bn in the US, suggesting a pressing global health challenge. Diabetes is a chronic metabolic disorder characterized by high blood sugar levels. In 2024, consensus global estimates suggested there were ~800m adult diabetes sufferers. In 2021, according to the IDF there >530m sufferers globally. For 2027E we modestly forecas...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Compass: Weekly Equity Strategy

S&P 500 Holding Above Prior Breakout Level Yet Again As discussed throughout the first half of January, we continue to believe that tariffs will mostly be used as a negotiation tactic, and much like Trump's prior presidency, will be much less impactful than feared. We reiterated this in yesterday's pre-market ETF Pathfinder, also noting "we anticipate the Canada/Mexico tariffs to be resolved relatively quickly, and therefore we view the latest pullback as a buying opportunity." Sure enough, bot...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Compass: Weekly Equity Strategy

S&P 500 Testing Prior Breakout Level DeepSeek appears to have turned the chatbot market upside-down, putting pressure on AI-linked stocks. While the dust has yet to settle, the good news is that the selloff has been largely contained to these AI-linked stocks. The rest of the market did not seem to care; the equal-weighted S&P 500 was roughly flat yesterday. Additionally, market dynamics remain healthy, with Treasury yields, the U.S. dollar (DXY), and WTI crude oil continuing to move lower, and...

Medtronic, Inc.: Update to credit analysis

Our credit view of this issuer reflects its strong product diversification, offset by its large payouts to shareholders.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch